RS, F., CL, F., CA, d., JC, W., KA, N., E, C., . . . SC, S. (1982). Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients. Antimicrobial agents and chemotherapy, 22(2), 193. https://doi.org/10.1128/AAC.22.2.193
Chicago Style (17th ed.) CitationRS, Finley, Fortner CL, deJongh CA, Wade JC, Newman KA, Caplan E, Britten J, Wiernik PH, and Schimpff SC. "Comparison of Standard Versus Pharmacokinetically Adjusted Amikacin Dosing in Granulocytopenic Cancer Patients." Antimicrobial Agents and Chemotherapy 22, no. 2 (1982): 193. https://doi.org/10.1128/AAC.22.2.193.
MLA (9th ed.) CitationRS, Finley, et al. "Comparison of Standard Versus Pharmacokinetically Adjusted Amikacin Dosing in Granulocytopenic Cancer Patients." Antimicrobial Agents and Chemotherapy, vol. 22, no. 2, 1982, p. 193, https://doi.org/10.1128/AAC.22.2.193.